Interestingly, a higher corticosterone-to-11-DHC ratio was associated with an increased tumor size in the combination group only, suggesting that low levels of corticosterone correlated with an improved response to anti-PD-1 treatment (Figure S7b–e). The gene discussed is PDCD1; the disease is neoplasm.